Amarin Stock Is Sinking After a Bearish Assessment of Its Heart Drug
Oppenheimer analyst Leland Gershell argues that the stock, which closed Tuesday at $22.73, will fall to $7 within 18 months.
https://finance.yahoo.com/m/87aa1bbb...html?.tsrc=rss
S&P500 (C Fund) (delayed) (Stockcharts.com Real-time) |
DWCPF (S Fund) (delayed) (Stockcharts.com Real-time) |
EFA (I Fund) (delayed) (Stockcharts.com Real-time) |
BND (F Fund) (delayed) (Stockcharts.com Real-time) |
||
Yahoo Finance Realtime TSP Fund Tracking Index Quotes |
Bookmarks